Facebook
Instagram
Linkedin
Soundcloud
Twitter
Youtube
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
A PROJECT OF THE INDEPENDENT INSTITUTE
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Home
2024
Yearly Archives: 2024
Blog
Ozempic Shortage Exposes FDA Challenges—but Telemedicine Offers Hope
Raymond March
-
December 30, 2024
0
Blog
Don’t Trust the Cabinet, Trust the Market
Raymond March
-
December 6, 2024
0
Blog
COVID-19 Vaccines and the Ratchet Effect: Lessons from
Crisis and Leviathan
Raymond March
-
November 25, 2024
0
Blog
If the FDA Wants People to Stop Smoking, it Should Stop Meddling in the Vaping Market
Raymond March
-
October 25, 2024
0
Blog
Supply, Demand, and Wegovy
Raymond March
-
October 24, 2024
0
Blog
What Would Kamala Harris’s FDA Look Like?
Raymond March
-
July 30, 2024
0
Blog
The Controversy Surrounding Microdosing Chocolate Bars
Raymond March
-
July 25, 2024
0
Blog
The FDA Is Coming After Microdosing Chocolate Bars
Raymond March
-
June 17, 2024
0
Blog
Why Are So Many Food and Beverage Products Being Recalled?
Raymond March
-
June 13, 2024
0
Blog
The FDA Is Not a Referee
Raymond March
-
May 3, 2024
0
1
2
Page 1 of 2
